Healthcare generative AI is predicted to reach $22 billion by 2032, driven by strategic partnerships and AI solutions in drug discovery, diagnostics, and patient care. The Generative AI Tracker, a collaboration between Pymnts and…
Continue Reading
UK-based digital health tech company Huma has received FDA 510(k) Class II clearance for its configurable disease-agnostic Software as a Medical Device platform, which includes the company’s cardiovascular risk score algorithm. The company, which received…
Continue Reading
Huma Therapeutics has received US Food and Drug Administration (FDA) Class II clearance for its disease-agnostic Software-as-a-Medical-Device (SaMD) platform, enabling companies to launch their own algorithm innovations more quickly to the platform and allowing…
Continue Reading
iPLATO has today announced that it has been awarded a £1.7 million research contract by Small Business Research Institute (SBRI) Healthcare, to improve bowel cancer screening rates across South East London.The programme will address…
Continue Reading
Bad news about his own health, brought home to Huma’s Dr Mert Aral the urgent need for digital tools to unlock personalised risk assessmentsIt was a complete shock. At age 35, there on my…
Continue Reading
